Injection molding payments are easier to manage when the purchase order separates tooling, sampling, production parts and approved extras. A single deposit and a final balance may look simple, but it can leave both sides arguing about what counts as tool completion, sample approval or production readiness. A milestone plan should connect each payment to evidence that the buyer can review and accept.

Use milestones to control scope and evidence, not to shift every programme risk to the supplier. The buyer still owns product requirements, approvals, forecasts and timely decisions; the supplier should clearly document the work included in its quotation.

01

Separate the commercial objects before setting percentages

Start by separating non-recurring tooling from recurring molded parts, engineering services, inspection, secondary operations, packaging and freight. Tooling may have its own payment schedule, while production parts should normally be paid against an accepted order, shipment or agreed credit term. Mixing these objects into one total makes it difficult to see whether a payment relates to steel and machining or to inventory that has already been delivered.

The commercial document should identify the controlled CAD revision, tool concept, cavity count, material direction, sample quantity, Incoterm, currency, taxes and validity period. Link the payment schedule to the same scope used for the quote; otherwise a change in geometry or volume can silently change the basis of the milestone plan. Buyers can use the [request-a-quote](/request-a-quote) page to present these assumptions before asking for a final schedule.

Injection molding RFQ scope review for payment milestone planning
Illustrative visual for engineering discussion; it does not depict an InjeForm customer part, facility, or production result.

02

What evidence should trigger each tooling payment?

A useful milestone is observable and reviewable. ‘Tool started’ is weaker than a dated design review, approved tool layout, documented steel order, completed machining stage or trial report. The exact evidence depends on the tool and agreement; a supplier should not be expected to disclose confidential subcontractor information, but it should provide enough proof that the agreed stage has been reached.

Avoid making sample approval an undefined subjective event. State the sample quantity, material, colour, dimensional report, visual standard, permitted deviations and response time. Approval can mean acceptance, conditional acceptance with a punch list, or rejection with reasons. The buyer remains responsible for defining product acceptance criteria; the supplier can recommend realistic inspection and correction steps.

MilestoneEvidence to requestBuyer decision
Design releaseApproved DFM response, tool layout, gate/parting-line intent and revision record.Release the tool to build or record open decisions.
Tool build progressStage report, dated photos or inspection evidence against the agreed build scope.Confirm the tool remains aligned with the PO and change log.
First trialTrial report, process notes, sample identification and visible defect log.Review whether corrections or a second trial are needed.
Sample approvalMeasured results, visual approval record and signed deviation list if applicable.Approve, conditionally approve or reject against stated criteria.
Production releaseApproved process/quality documents, packing confirmation and release status.Authorize routine production or hold for a defined action.

03

Balance supplier cash needs with buyer control

Toolmaking requires early expenditure on design, steel, standard components, machining and outside processes. A commercially workable schedule should fund legitimate committed work rather than assume the supplier can finance the entire build. At the same time, the buyer should avoid paying almost the full tool value before there is evidence of completion, trial and handover. The right balance depends on supplier relationship, tooling complexity, jurisdiction, currency exposure and the buyer’s risk controls.

Consider whether a retention amount, bank instrument, escrow arrangement or documented acceptance gate is appropriate for a material programme. These are commercial and legal decisions, not automatic injection molding rules. Have counsel review governing law, title, tax, insolvency, set-off, warranty and dispute language, especially for cross-border procurement in Europe, North America or the Middle East.

Injection mold tool build and trial stage for milestone evidence
Illustrative visual for engineering discussion; it does not depict an InjeForm customer part, facility, or production result.

04

Write change and delay rules before the first invoice

A payment plan cannot solve an uncontrolled scope. Define what happens when the buyer changes CAD, resin, finish, cavity count, packaging or annual volume after approval. Each change should state its price impact, schedule impact, responsible approver and whether it affects a completed milestone. A supplier recommendation is not automatically a buyer-approved product change, and a buyer request is not automatically included in the original tooling price.

Also define delay categories. A buyer may delay a gate decision or sample approval; a supplier may miss an agreed trial date; a third party may delay steel or texture. Record the cause, revised date, mitigation and cost treatment. The process page at [/process](/process) can help buyers frame the expected handoffs, but the purchase agreement should control the actual obligations.

05

Make the final release about usable handover

The last tooling payment should correspond to more than a polished sample. Confirm that the tool identity, cavity count, approved material direction, trial history, correction status, maintenance expectations, spare-parts list and agreed technical data are handed over or stored as agreed. If the supplier will retain the mold, document custody, access, maintenance authorization and exit or transfer terms.

For routine parts, define whether payment is tied to shipment, receipt, inspection, acceptance or a credit term. Buyers should not use payment withholding as a substitute for a written nonconformance process. A clear quality route—described alongside the supplier’s [quality](/quality) information—allows both parties to distinguish a commercial invoice dispute from a genuine product or documentation issue.

Injection molding production and delivery planning after sample approval
Illustrative visual for engineering discussion; it does not depict an InjeForm customer part, facility, or production result.

Practical takeaway

Before you move
to the next review.

  • Separate tooling, parts, inspection, secondary work, packaging and freight into visible commercial lines.
  • Tie every milestone to objective evidence, an owner and a review response time.
  • Define sample acceptance criteria, conditional approval and deviation handling before trials.
  • Document engineering changes, delays, taxes, currency, title and cross-border legal review.
  • Make final release depend on usable tool, quality and technical handover—not only a date.

FAQ

Common questions

Should the final tooling payment wait until production parts are approved?

Not always. A tool can be accepted after documented trials and agreed corrections, while production approval follows a separate part-quality process. The contract should define both gates.

Is a 50/50 tooling payment schedule suitable for every mold?

No. Cavity count, complexity, supplier relationship, jurisdiction, programme risk and evidence requirements should shape the schedule. Percentages are commercial terms, not technical standards.

Who is responsible for defining sample acceptance?

The buyer or product owner should define functional, dimensional, visual and regulatory acceptance requirements. The supplier can advise on measurable inspection and realistic correction steps.

Can a buyer withhold payment for an unapproved design change?

Only according to the agreed contract and change process. Record the requested change, approval status, scope impact and invoice relationship rather than relying on informal withholding.

What should happen if a supplier misses a trial date?

Record the cause, revised plan, mitigation and any agreed commercial remedy. Distinguish supplier-caused delay from buyer decisions, third-party events or an approved scope change.

References

Source material

  1. [1] ISO, “ISO 9001 — Quality management systems.”
  2. [2] U.S. Federal Acquisition Regulation, “Changes.”
  3. [3] Fictiv, “Injection Molding Design Guide: Best Practices for Molded Plastic Parts.”
  4. [4] Protolabs, “Injection Molding Design Guidelines.”

This guide is general information for early procurement and engineering discussion. It does not replace product-specific DFM, qualification, validation, regulatory assessment or legal advice.